55CLINICAL STUDIES PEDIATRIC STUDIES

Conclusions Traumeel® proved effective in all pediatric age groups (infants, pre-schoolers and

school-age children) and for all of the usage indications reported. Traumeel® is reliably effective in treating both blunt trauma and muscle, joint and

soft-tissue disorders of varying etiology in pediatric patients.

Results Overall analysis of the therapeutic results indicated that the treatment was rated

(regardless of age or type of symptoms) as very good in 70% of patients and good in 27% of patients (Figure 23).

Monotherapy with Traumeel® was rated as very good or good in 98% of patients.

Symptoms improved within 1 day of application in 7% of patients, and within 1 3 days in two thirds of the patients. A further 24% saw improvement by the end of the first week of treatment.

Pe rc

en ta

ge o

f p at

ie nt

s

Very good Good Satisfactory No improvement

100

90

80

70

60

50

40

30

20

10

0 A B Fc D E

A = total patient population (n=157) B = contusions (n=50) C = sprains (n=37)

D = hematomas (n=26) E = dislocations (n=11) F = Traumeel® monotherapy (n=97)

Figure 23 Results of therapy with Traumeel®.